PQRS Measure
#251Immunohistochemical (IHC) Evaluation of Human Epidermal Growth Factor Receptor 2 Testing (HER2) for Breast Cancer Patients
Report via: Claim, Registry
The following codes apply for this PQRS measure:
CPT Codes | |||
| Code | Modifier | POS | Description |
|---|---|---|---|
| 88360 | N/A | N/A | Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; manual |
| 88361 | N/A | N/A | Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; using computer-assisted technology |
| 3394F | 8P | N/A | Quantitative HER2 immunohistochemistry (IHC) evaluation of breast cancer consistent with the scoring system defined in the ASCO/CAP guidelines (PATH) |
| 3394F | N/A | N/A | Quantitative HER2 immunohistochemistry (IHC) evaluation of breast cancer consistent with the scoring system defined in the ASCO/CAP guidelines (PATH) |
| 3395F | N/A | N/A | Quantitative non-HER2 immunohistochemistry (IHC) evaluation of breast cancer (eg, testing for estrogen or progesterone receptors [ER/PR]) performed (PATH) |
| 3394F | 8P | N/A | Quantitative HER2 immunohistochemistry (IHC) evaluation of breast cancer consistent with the scoring system defined in the ASCO/CAP guidelines (PATH) |
| 3394F | N/A | N/A | Quantitative HER2 immunohistochemistry (IHC) evaluation of breast cancer consistent with the scoring system defined in the ASCO/CAP guidelines (PATH) |
ICD9 Codes | |||
| Code | Modifier | POS | Description |
| 174.0 | N/A | N/A | Malignant neoplasm of nipple and areola of female breast |
| 174.1 | N/A | N/A | Malignant neoplasm of central portion of female breast |
| 174.2 | N/A | N/A | Malignant neoplasm of upper-inner quadrant of female breast |
| 174.3 | N/A | N/A | Malignant neoplasm of lower-inner quadrant of female breast |
| 174.4 | N/A | N/A | Malignant neoplasm of upper-outer quadrant of female breast |
| 174.5 | N/A | N/A | Malignant neoplasm of lower-outer quadrant of female breast |
| 174.6 | N/A | N/A | Malignant neoplasm of axillary tail of female breast |
| 174.8 | N/A | N/A | Malignant neoplasm of other specified sites of female breast |
| 174.9 | N/A | N/A | Malignant neoplasm of breast (female), unspecified |
| 175.0 | N/A | N/A | Malignant neoplasm of nipple and areola of male breast |
| 175.9 | N/A | N/A | Malignant neoplasm of other and unspecified sites of male breast |
Legend:
ClaimThis measure can be submitted via claim. Use the 'Data Collection' pdf associated with the measure.
GroupThis measure can be submitted through one or more groups. Click on the group name to view the group information.
RegistryThis measure can be submitted through registry.
EHRThis measure can be submitted via Electronic Health Record (EHR).
GPRO IThis measure can be submitted via Group Practice Reporting Option 1.
GPRO IIThis measure can be submitted via Group Practice Reporting Option 2.
More information on these alternative reporting mechanisms is available at:
http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
ClaimThis measure can be submitted via claim. Use the 'Data Collection' pdf associated with the measure.
GroupThis measure can be submitted through one or more groups. Click on the group name to view the group information.
RegistryThis measure can be submitted through registry.
EHRThis measure can be submitted via Electronic Health Record (EHR).
GPRO IThis measure can be submitted via Group Practice Reporting Option 1.
GPRO IIThis measure can be submitted via Group Practice Reporting Option 2.
More information on these alternative reporting mechanisms is available at:
http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com